Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

More than 25.000 patients enrolled in pivotal clinical trials, 3.200 patent applications, 273 of which priority; 6 innovative drugs registered internationally (in the cardiovascular, anti-infective, analgesia areas) available in over 70 European and non-European countries.

We rely on research to develop new drugs for the cure of diseases that are still without effective solutions and thus improve the quality of life of patients.


MEN1112 MEN1309 HUMANIZED MONOCLONAL ANTIBODIES Dexketoprofen+Tramadol

THERAPEUTIC AREAS

 

Discover all of Menarini's products marketed in Italy.

READ MORE »

DIAGNOSTICS

 

Advanced Technology

READ MORE »

THE MENARINI GROUP

 

Discover the leading Italian pharmaceutical company in the world.

READ MORE »

QUALITY FIRST

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »